In contrast, the increased expression of ALKBH5 promoted m6A demethylation and the stability of GLUT4 mRNA in a YTHDF2-dependent manner, which resulted in enhanced glycolysis in drug-resistant breast cancer cells [33]. Here, ALKBH5 is linked to breast cancer.